Janssen averse to extrapolation as FDA sits to review Remicade biosimilar
Celltrion’s CT-P13 has been declared “highly similar” in safety and efficacy to J&J’s Remicade, and could be recommended for approval by a US FDA committee today.
Archives for February 9, 2016
Lonza to make Kodiak Sciences' eye drug candidates
Lonza has been contracted to make candidate antibody-based drugs for retinal diseases by California, US biotech Kodiak Sciences.